Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Most Canadian licensed producers are likely sitting on underutilized or unused assets that they won't be able to move.

Aurora Cannabis' Exeter Sale Confirms the Need for Industrywide Writedowns

Aurora stock is still a high-risk stock for cannabis investors. However, its near-term financial situation may not be as bad as feared.

Don’t Buy Aurora Stock Just Yet

The company's revenue was an improvement from the previous quarter, but Aurora still posted a loss.

Is Aurora Cannabis a Buy After Its Q3 Results?

Cronos Group

Which stock wins in a battle between these two well-known Canadian cannabis producers?

Better Marijuana Stock: Aurora Cannabis vs. Cronos Group

Is the pot company ready to stage a comeback?

Why Is Everyone Talking About Aurora Cannabis?

Beating revenue expectations doesn't make up for a lack of efficiency in its value chain.

Could Aurora Cannabis Turn Its Q3 Success Into Long-Term Growth?

"Stocking up" behavior helped boost dispensary revenue.

Canada Licensed Marijuana Sales Jumped 19% in March

Could the marijuana leader's stock be worth only $10?

Why Aurora Cannabis Stock Dropped on Friday

The euphoria that followed the announcement Wednesday that Aurora Cannabis Inc. (NYSE: ACB) is acquiring Reliva LLC was subsiding Friday.

Reliva Acquisition Fervor for Aurora Cannabis Stock Cools

Amplify Alternative Harvest ETF

Canopy Growth

Tilray Brands

Cannabis company stocks are skyrocketing as investors are high on new hopes that marijuana might help ward off the deadly coronavirus.

Cannabis stocks soar on hopes pot wards off coronavirus

Aurora's acquisition history is less than stellar.

Aurora Cannabis Finally Enters the U.S. -- Here's Why You Should Hold the Applause

Jefferies downgraded Aurora Cannabis Inc. stock ACB, +36.47% ACB, +35.31% on Friday to underperform from hold and said the recent re-rating following better-than-expected earnings was neither justified nor sustainable.

Aurora Cannabis downgraded by Jefferies as re-rating 'neither justified nor sustainable'

Aurora Cannabis on track to make patient investors very happy

Aurora Cannabis: Blossoming Opportunity in a Battered Industry

The marijuana leader struck a blockbuster deal to enter a massive new market.

Why Aurora Cannabis Stock Is Rocketing Higher Today

Aurora Cannabis Inc (NYSE: ACB) shares are on a roll yet again, this time in reaction to its announcement that it is entering the U.S.

Aurora Cannabis Analysts On Pros, Cons Of Entry Into US CBD Market

The marijuana leader is seizing a major new growth opportunity.

Aurora Cannabis Strikes a Deal to Enter the U.S. CBD Market

Despite being the first industrialized country to legalize adult-use pot in the modern era, Canada's ambitions of being a marijuana leader have gone up in smoke.

Here's How Canada Blew Its Chance to Be a Cannabis Leader

Cantor Fitzgerald reiterated its overweight rating on shares of Aurora Cannabis Inc.

Aurora Cannabis reiterated as overweight as Cantor Fitzgerald welcomes Reliva deal

Are better-than-expected financial results enough to make this recovering pot stock a buy?

Is Aurora Cannabis Finally Making a Recovery?

Aurora Cannabis spiked late Wednesday after the Canadian pot producer announced an acquisition to enter the U.S. retail CBD market for the first time.

Aurora Cannabis Jumps On Deal To Enter U.S. Retail CBD Market While Rivals Balk

Aurora Cannabis (NYSE: ACB) announced Wednesday afternoon it will acquire CBD platform Reliva for $40 million in Aurora common shares.

Aurora Cannabis Buys Reliva, Enters US CBD Market

Aurora Cannabis Inc. ACB, -12.96% ACB, -12.69% said late Wednesday that it was acquiring U.S.

Aurora Cannabis to acquire U.S. CBD brand Reliva for $40 million in stock

Aurora Cannabis has agreed to buy U.S.-based CBD company Reliva, giving the struggling Canadian company a business foothold in America.

Canada's Aurora Cannabis makes a CBD deal to enter the lucrative U.S. market

Some analysts are questioning whether the marijuana company's recent gains are justified.

Why Aurora Cannabis Stock Is Falling Today

Beaten up for most of this year, Aurora stock finally looks interesting after encouraging results from the company’s fiscal Q3 earnings report. While still incredibly risky, ACB can move higher based on longer-term developments.

News for Aurora Cannabis Stock (ACB)